dabigatran has been researched along with Myotonic Dystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arena, G; Cassese, A; Golino, P; Mosella, M; Palladino, A; Papa, AA; Rago, A | 1 |
| Cassese, A; Cimmino, G; Cioppa, ND; Gallinoro, E; Golino, P; Magliocca, MCG; Papa, AA; Rago, A; Sperlongano, S | 1 |
2 other study(ies) available for dabigatran and Myotonic Dystrophy
| Article | Year |
|---|---|
Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation.
Topics: Administration, Oral; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Heart Atria; Humans; Middle Aged; Myotonic Dystrophy; Thrombosis | 2017 |
Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.
Topics: Antithrombins; Dabigatran; Female; Humans; Middle Aged; Myotonic Dystrophy; Pulmonary Embolism | 2018 |